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Edited by Peter BrzezinskiAbstract The biosynthesis of D-threo-tetrahydrobiopterin
(DH4, tetrahydrodictyopterin) in Dictyostelium discoideum
Ax2 was investigated through the mutant disrupted in the gene
encoding sepiapterin reductase (SR) by insertional inactivation.
The mutant cells, being completely devoid of SR protein, showed
18.1% of L-erythro-tetrahydrobiopterin (BH4) and 0.6% of DH4
productions in the wild type cells. The mutant cells were also iden-
tiﬁed to excrete D- and L-sepiapterin, which were presumed to
originate from intracellular 1 0-oxo-2 0-D-hydroxypropyl- and 1 0-
oxo-2 0-L-hydroxypropyl-tetrahydropterin (H4-pterin), respec-
tively. Furthermore, in a coupled assay with Dictyostelium SR,
the mutant cell extract exhibited a novel enzyme activity convert-
ing 6-pyruvoyltetrahydropterin to 1 0-oxo-2 0-D-hydroxypropyl-
H4-pterin. These results are clear demonstration of the in vivo
synthesis of DH4 via 1 0-oxo-2 0-D-hydroxypropyl-H4-pterin as
well as an alternative synthesis of BH4 and DH4 in the complete
absence of SR.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Dictyostelium1. Introduction
L-erythro-tetrahydrobiopterin (BH4) is ubiquitous in nature
and a multifaceted molecule. It has a well-known biochemical
function in higher animals as a cofactor for aromatic amino
acid hydroxylation, nitric oxide synthesis, and glyceryl-ether
hydroxylation [1].
The de novo biosynthesis of BH4 from guanosine 5 0-triphos-
phate (GTP) is accomplished by GTP cyclohydrolase I
(GTPCH; EC 3,5,4,16), 6-pyruvoyltetrahydropterin synthase
(PTPS; EC 4.2.3.12), and sepiapterin reductase (SR;Abbreviations: AR, aldose reductase; BH4, L-erythro-tetrahydrobiop-
terin; CR, carbonyl reductase; Dic-SR, Dictyostelium SR; DH4, D-
threo-tetrahydrobiopterin; GTP, guanosine 50-triphosphate; GTPCH,
GTP cyclohydrolase I; H2-NTP, dihydroneopterin triphosphate; H4-
pterin, tetrahydropterin; PPH4, 6-pyruvoyltetrahydropterin; PTPS, 6-
pyruvoyltetrahydropterin synthase; SR, sepiapterin reductase
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doi:10.1016/j.febslet.2005.04.0641.1.1.153) [1]. GTPCH catalyzes the synthesis of dihydroneop-
terin triphosphate (H2-NTP), which is transformed to 6-pyru-
voyltetrahydropterin (PPH4) by PTPS. The diketo compound
is reduced further to BH4 by SR. SR carries out two consecu-
tive reductions of C1 0 carbonyl group via isomerization reac-
tion [2–5]. BH4 synthesis is also mediated by aldose
reductase (AR; 1.1.1.21) in animals [6,7]. AR speciﬁcally re-
duces C2 0 carbonyl group and generates 1 0-oxo-2 0-L-hydroxy-
propyl-tetrahydropterin (H4-pterin), which is further reduced
to BH4 by SR. In the complete absence of SR activity, an alter-
native synthesis of BH4 was suggested to be possible by car-
bonyl reductase (CR) and AR [7] and was recently
demonstrated in vivo through ﬁnding of human patients deﬁ-
cient in SR [8]. BH4 has two chiral carbons in its C6-side chain
and therefore can exist as four diﬀerent isomers. Hitherto,
three isomers have been known in nature: L-erythro isomer
is a common form, L-threo isomer from Chlorobium tepidum
[9], and D-threo isomer from Dictyostelium discoideum [10].
A multicellular eukaryote D. discoideum is an useful model
organism for cellular and developmental research and is noto-
rious for its synthesis of a D-threo-BH4, named tetra-
hydrodictyopterin (DH4), together with a much lower
amount of L-erythro form [10,11]. However, the DH4 synthesis
remained unknown. The synthesis of DH4 was suspected to
originate either from PPH4 or epimerization of L-erythro-
BH4, but no relevant activity was identiﬁed from the organism
[11]. Recombinant Dictyostelium SR (Dic-SR) alone converted
PPH4 to BH4 but never to DH4 [12], while Chlorobium SRs
produced L-threo-BH4 [13]. In order to elucidate the biosyn-
thesis, we disrupted the SR gene in D. discoideum Ax2 and
investigated the tetrahydropteridine production by the mutant
and an involved enzyme activity.2. Materials and methods
2.1. Cell growth and transformation
Dictyostelium discoideum Ax2 cells were grown vegetatively at 22 C
in HL5 medium (15.4 g glucose, 7.15 g yeast extract, 14.3 g protease
peptone, 0.485 g KH2PO4, 1.28 g Na2HPO4 12H2O, pH 6.5, per liter)
with 100 lg/ml streptomycin sulfate and 100 U/ml benzylpenicillin
potassium [14]. To select transformant HL5 medium was supple-
mented with 10 lg/ml blasticidin S [15]. Transformation was per-
formed with S phase synchronized method [16]. Cells were
synchronized in S phase by incubation at 9.6 C for 14 h followed by
incubation at 22 C for 2.5 h at a density of 1.0 · 106 cells/ml in HL5
medium. After synchronization, cells were harvested by centrifugation
at 350 · g for 3 min and resuspended in electroporation buﬀer (10 mMation of European Biochemical Societies.
Fig. 1. Identiﬁcation of the SR gene disruption in the mutant.
(A) PCR ampliﬁcation of SR gene from the genomic DNAs of wild
type (W) and the mutant cells (M). (B) Southern blot analysis of PstI-
digested genomic DNAs of wild type and the mutant. (C) Immunoblot
analysis of total proteins from wild type and the mutant cells separated
by SDS–PAGE.
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500 ll aliquot of the cell suspension was mixed with 10 lg of DNA
and electroporated with a Transfector 800 (BTX) (0.85 kV, 2 times).
After incubating on ice for 5 min, the cells were transferred into Petri
dish containing 20 ml of HL5 medium. The cells were incubated at
22 C for 24 h and then 0.4 lg of blasticidin S was added to the med-
ium. The medium was changed every 3 days. Clones that were alive in
the selection medium were isolated between 7 and 10 days. Colonial
selection of transformant was accomplished by plating the cells on
5LP agar (0.5% lactose and 0.5% Difco peptone with 1.5% agar) with
Klebsiella aerogenes or Escherichia coli BL21(DE3). The colony cells
were ﬁnally inoculated into Petri dish containing 20 ml of HL5.
2.2. DNA manipulation
To make the disruption construct for Dictyostelium SR gene, the
1.4 kb blasticidin resistance gene (bsr) cassette was digested from pUC-
BsrDBam plasmid [17] with BamHI and HindIII, blunted at both ends
with Klenow fragment and then ligated into the blunted-endedHindIII
site of the SR cDNAwhich had previously been cloned in pGEMT-easy
vector [12]. PCR ampliﬁcation of the SR cDNA or genomic DNA was
performed with the primers (forward, aattgttacaggtgcaagtaaaggattt; re-
verse, ctaaatcataataatctaaatgagaaccagtttc) at an annealing temperature
of 55 C.
Southern hybridization was performed with 20 lg of PstI-digested
genomic DNAs. RNA probe was prepared from the SR cDNA using
a DIG-labeling kit (Roche Applied Science). Genomic DNAs were sep-
arated in 0.8% agarose gel and transferred onto a nylon membrane.
The membrane was subjected to hybridization using DIG-labeled
RNA probe and ULTRAhyb hybridization buﬀer (Ambion) as fol-
lows: hybridization and washing at 68 C, prehybridization for
30 min, hybridization for 2–5 h, low stringency washing (2 · SSC,
0.1% SDS) for 5 min twice and ﬁnally high stringency washing
(0.1 · SSC, 0.1% SDS) for 15 min twice. The hybridized membrane
was subjected to immunological detection using an anti-digoxigenin
antibody conjugated to alkaline phosphatase following the kit manual.
Color was developed using nitroblue tetrazolium and 5-bromo-4-
chloro-3-indolyl phosphate for 16 h.
2.3. Pteridine analysis
Pteridine compounds were analyzed by HPLC after oxidation with
acidic iodine solution unless stated otherwise [13]. Samples were mixed
with an equal volume of acidic iodine solution (2% KI/1% I2 in 1 M
HCl) for 2 h in the dark. After centrifugation, the supernatant was
mixed with ascorbic acid and subjected to HPLC. For intracellular
pteridine analysis cells equivalent to 5 · 107 cells were suspended in
100 ll of 10 mM Tris, 1 mM EDTA, pH 8.0, and subjected to iodine
oxidation. To distinguish tetrahydro form of pteridines from dihydro
forms [18] iodine oxidation was performed in alkaline solution (2%
KI/1% of I2 in 0.2 N NaOH) following the procedure described above.
In order to analyze extracellular pteridines, cells were harvested
from vegetative growth, transferred to 12 mM phosphate buﬀer (pH
6.5), and cultured at 22 C for 4 h. Ten milliliters of the culture super-
natant was freeze dried, dissolved in 150 ll of water, and then applied
to a C18 Sep-Pak cartridge (Waters Associates). The cartridge was
washed with 3 ml of water and then eluted with 1 ml of methanol.
After evaporation of methanol, the residue was dissolved in 100 ll of
water and an aliquot was directly subjected to HPLC for identiﬁcation
of sepiapterin. Another aliquot was incubated with recombinant Dic-
SR (1 lg) and 0.4 mMNADPH to convert sepiapterin to dihydrobiop-
terin and then oxidized with iodine solution for HPLC analysis.
HPLC was performed with a C18 column and a ﬂuorescence detec-
tor (HP Model 1046A) at a constant ﬂow rate of 1.2 ml min1. C18
columns were Inertsil ODS-3 (5 lm, 150 · 2.3 mm, GL Science, Japan)
and Shodex ODSpak F-411 (5 lm, 150 · 2.3 mm, Showa Denko K.K.,
Japan). Sepiapterin was eluted isocratically with 8% aqueous methanol
and monitored at 425 nm/530 nm (ex/em). The other pteridines were
eluted isocratically with 10 mM sodium phosphate (pH 6.0) and mon-
itored at 350 m/450 nm (ex/em). Authentic pteridines were purchased
from Dr. Schircks Laboratories (Jona, Switzerland).
2.4. In vitro assay of DH4 synthesis
The assay of AR-like enzyme activity was carried out in a reaction
volume of 50 ll containing 50 mM potassium phosphate (pH 6.5),
0.4 mM NADPH, 10 mM dithiothreitol, aliquots of H2-NTP, and en-zyme solutions (10 ll of the SR mutant crude extract, 0.75 lg of Dic-
SR, and 55 ng of recombinant human PTPS). The crude extract was
prepared freshly grown cells. Cells equivalent to 1 · 108 were sus-
pended in 50 ll of 50 mM potassium phosphate (pH 6.5), 1 mM
DTT, ruptured by three times of freeze-thawing procedure, and centri-
fuged at 15 000 rpm for 20 min to discard precipitate. H2-NTP was
prepared from GTP by incubation with recombinant Synechocystis
sp. PCC 6803 GTPCH [19]. The recombinant proteins of Dic-SR
and human PTPS were from the previous results [12,20]. The reaction
mixture was incubated at 22 C for 2 h and stopped by adding an equal
volume of acidic iodine solution. The centrifugal supernatant was sub-
jected to HPLC as described above.
2.5. Miscellaneous methods
SDS–PAGE was performed on denaturing conditions with a 12.5%
polyacrylamide gel. Immunoblot analysis of Dic-SR was carried out
with an anti-serum prepared against the puriﬁed recombinant protein
[12]. Protein was measured by the Bradford method using bovine ser-
um albumin as a standard.3. Results and discussion
3.1. Gene disruption of SR
The SR gene disruption was performed by homologous
recombination using a knockout vector containing 1.4 kb bsr
cassette in the middle of 0.8 kb SR cDNA. The transformant
was identiﬁed by PCR ampliﬁcation of a 2.2 kb DNA frag-
ment harboring bsr insert in the SR gene (Fig. 1A). The
replacement of SR gene in the mutant was conﬁrmed by geno-
mic Southern and Western blot analyses (Fig. 1B and C).
Absolutely no wild type copy of the SR gene or SR protein
Fig. 3. HPLC analysis of extracellular pteridines in the mutant culture
medium. (A) Identiﬁcation of sepiapterin. Trace I, standard L-
sepiapterin; trace II, the culture concentrate prepared from the
mutant. (B) Identiﬁcation of biopterin converted from sepiapterin.
The sepiapterin samples used in (A) were incubated with SR and
oxidized with iodine solution. Trace I, prepared from the standard L-
sepiapterin; trace II, prepared from the culture concentrate. Sepiap-
terin was eluted with 8% aqueous methanol and biopterin was with
10 mM sodium phosphate (pH 6.0) on a C18 column (Inertsil ODS-3).
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of the SR gene in the mutant.
3.2. Pteridine production by the mutant cells
Pteridine production was investigated in the mutant cells by
HPLC after iodine oxidation (Fig. 2). As known previously
[11], wild type cells exhibited a small peak of L-erythro-biop-
terin followed by a major peak of D-threo-biopterin (dictyop-
terin), the fully oxidized form of DH4. Expectedly, the mutant
cells manifested much decreased pteridine production, but not
completely (Fig. 2B). They were determined to be 18.1% (L-er-
ythro-biopterin) and 0.6% (D-threo-biopterin) of the wild type
level. When the pteridines were oxidized in alkaline condition,
both were barely detectable (Fig. 2C), supporting that they
mostly existed as tetrahydro forms. The results demonstrated
an alternative synthesis of BH4 and DH4 in Dictyostelium in
the absence of SR. The alternative synthesis of BH4 in vivo
was suggested to be possible by the activities of CR(s) and
AR [6,7] and recently identiﬁed in human SR deﬁcient patients
[8].
Dic-SR was demonstrated in vitro to produce only BH4
from PPH4 [13]. However, the simultaneous decrease of both
BH4 and DH4 syntheses by SR gene inactivation (Fig. 2B)
suggested that SR was somehow implicated in the synthesis
of DH4 in vivo. It was well known that SR speciﬁcally reduces
C1 0 carbonyl group of PPH4 and catalyzes two successive steps
of reduction in situ via isomerization. Animal AR also partic-
ipates in the process by speciﬁcally reducing C2 0 carbonyl
group of PPH4 [6,7], providing 1 0-oxo-2 0-L-hydroxypropyl-
H4-pterin to SR for a ﬁnal reduction to BH4. Therefore, it
was speculated that in Dictyostelium DH4 synthesis might oc-
cur in two steps: C2 0 carbonyl reduction of PPH4 by a putative
AR-like enzyme, which in contrast to animal AR would cata-
lyze D-threo-type reduction, followed by reduction of C1 0 car-
bonyl group by SR. This hypothesis drove us to investigate the
possible accumulation of an intermediate, which was presum-
ably 1 0-oxo-2 0-D-hydroxypropyl-H4-pterin, in the mutant. As
the intermediate was expected to be excreted as an oxidizedFig. 2. HPLC analysis of pteridines in the wild type and mutant cells.
Acidic iodine oxidized intracellular pteridines from wild type (A) and
the SR mutant (B). (C) Alkaline iodine oxidized intracellular pteridines
from the mutant. (D) Standard pteridines: (a) neopterin; (b) pterin; (c)
L-erythro-biopterin; (d) 6-hydroxymethylpterin; (e) D-threo-biopterin.
The oxidized samples were chromatographed on a C18 column
(Inertsil ODS-3) with 10 mM sodium phosphate (pH 6.0).form 1 0-oxo-2 0-D-hydroxypropyl-dihydropterin (D-sepiap-
terin), the mutant culture medium were analyzed for the com-
pound by HPLC (Fig. 3). A single peak corresponding to
standard L-sepiapterin was eluted from the mutant sample
(Fig. 3AII), while none from the wild type sample (data not
shown). As the peak was suspected to be a mixture of L- and
D-sepiapterin, the sample was incubated with SR in order to
convert them to non-enantiomeric biopterin isomers. Expect-
edly, HPLC analysis of the reaction mixture exhibited two
peaks at the corresponding positions of L-erythro- and D-
threo-biopterin (Fig. 3BII). The ﬁnding of D-sepiapterin
strongly supported our assumption that the DH4 synthesisFig. 4. Identiﬁcation of AR-like enzyme activity. (A) The reaction
mixture of Dic-SR and human PTPS (hPTPS). (B) The reaction mix-
ture of Dic-SR and the mutant crude extract (c.e). (C) The reaction
mixture of Dic-SR, human PTPS, and the crude extract. (D) Standard
pteridines as shown in Fig. 2. The iodine oxidized reaction mixtures
were analyzed by HPLC on a C18 column (Shodex ODSpak F-411).
Fig. 5. Proposed biosynthesis of tetrahydropteridines in Dictyostelium discoideum Ax2. The BH4 and DH4 syntheses are bifurcated from PPH4. The
dominant synthesis of DH4 in vivo is constituted by AR-like enzyme and SR, while BH4 production depends on SR alone. In the absence of SR,
CR(s) may replace the role of SR, allowing alternative synthesis of BH4 and DH4.
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D-hydroxypropyl-H4-pterin. In analogy, L-sepiapterin may
have originated from 1 0-oxo-2 0-L-hydroxypropyl-H4-pterin,
which might be an incomplete reaction product of CR(s).
3.3. AR-like enzyme activity
The high possibility of in vivo synthesis of 1 0-oxo-2 0-D-
hydroxypropyl-H4-pterin prompted us to assay the putative
AR-like enzyme activity in the mutant cell extract. Chromato-
grams of the assay result are shown in Fig. 4. As known pre-
viously [13], the reaction mixture of Dic-SR and human
PTPS exhibited only L-erythro-biopterin (Fig. 4A). When the
mutant crude extract was incubated with Dic-SR, however,
D-threo-biopterin peak appeared (Fig. 4B) and increased more
with addition of human PTPS (Fig. 4C). Thus, it was clear that
there was AR-like enzyme in the crude extract generating DH4
from PPH4 when coincubated with SR. In order to identify the
immediate enzymatic product of the AR-like activity, the reac-
tion mixture of the crude extract and human PTPS was ana-
lyzed by HPLC following the same procedure performed for
demonstration of Fig. 3. The chromatography results, which
were found to be a replicate of Fig. 3IIs and therefore not
shown here, showed the presence of both D- and L-sepiapterin,
verifying the production of 1 0-oxo-2 0-D-hydroxypropyl-H4-
pterin from PPH4 by AR-like enzyme. It should be determined
in the future whether the AR-like enzyme is a genuine struc-
tural homologue of animal AR and how it catalyzes the syn-
thesis of a diﬀerent stereoisomer.
Our results are summarized in the proposed biosynthetic
pathway of BH4 and DH4 (Fig. 5). We created a D. discoid-
eum Ax2 mutant disrupted in the SR gene and characterized
the mutant for pteridine production. Through HPLC identi-
ﬁcation of intra- and extracellular pteridines of the mutant
cells and in vitro assay products we demonstrated that
DH4 synthesis from PPH4 in D. discoideum Ax2 occurs
via 1 0-oxo-D-hydroxypropyl-H4-pterin by a novel enzyme
activity of AR-like. The results also manifested an alterna-
tive synthesis of BH4 and DH4 in the organism, putatively
being catalyzed by CR(s) and AR-like enzyme, in the ab-
sence of SR. Our results provide a new opportunity to initi-ate the study of BH4 and DH4 in Dictyostelium, which is an
important model organism for cellular and developmental
research.
Acknowledgments: Y.K. Choi was supported by 2004 INJE University
Postmaster Research Grant. This research was supported by a KOSEF
grant (R05-2003-000-11206-0).References
[1] Tho¨ny, B., Auerbach, G. and Blau, N. (2000) Tetrahydrobiop-
terin biosynthesis, regeneration and functions. Biochem. J. 347, 1–
16.
[2] Katoh, S. and Sueoka, T. (1984) Sepiapterin reductase exhibits a
NADPH-dependent dicarbonyl reductase activity. Biochem. Bio-
phys. Res. Commun. 118, 859–866.
[3] Katoh, S. and Sueoka, T. (1987) Isomerization of 6-lactoyl
tetrahydropterin by sepiapterin reductase. J. Biochem. 101, 275–
278.
[4] Katoh, S. and Sueoka, T. (1988) Coenzyme stimulation of
isomerase activity of sepiapterin reductase in the biosynthesis of
tetrahydrobiopterin. J. Biochem. 103, 286–289.
[5] Auerbach, G., Herrmann, A., Gu¨tlich, M., Fisher, M., Jacob, U.,
Bacher, A. and Huber, R. (1997) The 1.25 A˚ crystal structure of
sepiapterin reductase reveals its binding mode to pterins and brain
neurotransmitters. EMBO J. 16, 7219–7230.
[6] Milstien, S. and Kaufman, S. (1989) Immunological studies on the
participation of 6-pyruvoyl tetrahydropterin (2 0-oxo) reductase,
an aldose reductase, in tetrahydrobiopterin biosynthesis. Bio-
chem. Biophys. Res. Commun. 165, 845–850.
[7] Park, Y.S., Heizmann, C.W., Wermuth, B., Levine, R.A.,
Steinerstauch, P., Guzman, J. and Blau, N. (1991) Human
carbonyl and aldose reductases: new catalytic functions in
tetrahydrobiopterin biosynthesis. Biochem. Biophys. Res. Com-
mun. 175, 738–744.
[8] Bonafe, L., Tho¨ny, B., Penzien, J.M., Czarnecki, B. and Blau, N.
(2001) Mutations in the sepiapterin reductase gene cause a novel
tetrahydrobiopterin-dependent monoamine-neurotransmitter
deﬁciency without hyperphenylalaninemia. Am. J. Hum. Genet.
69, 269–277.
[9] Cho, S.H., Na, J.U., Youn, H., Hwang, C.S., Lee, C.H. and
Kang, S.O. (1998) Tepidopterin, 1-O-(L-threo-biopterin-20-yl)-
beta-N-acetylglucosamine from Chlorobium tepidum. Biochim.
Biophys. Acta 1379, 53–60.
[10] Klein, R., Thiery, R. and Tatischeﬀ, I. (1990) Dictyopterin,
6-(D-threo-1,2-dihydroxypropyl)-pterin, a new natural isomer
Y.K. Choi et al. / FEBS Letters 579 (2005) 3085–3089 3089of L-biopterin. Isolation from vegetative cells of Dictyostelium
discoideum and identiﬁcation. Eur. J. Biochem. 187, 665–669.
[11] Gu¨tlich, M., Witter, K., Bourdais, J., Veron, M., Ro¨dl, W. and
Ziegler, I. (1996) Control of 6-(D-threo-10,2 0-dihydroxypropyl)
pterin (dictyopterin) synthesis during aggregation of Dictyoste-
lium discoideum. Involvement of the G-protein-linked signalling
pathway in the regulation of GTP cyclohydrolase I activity.
Biochem. J. 314, 95–101.
[12] Kim, Y.A., Chung, H.J., Kim, Y.J., Choi, Y.K., Hwang, Y.K.,
Lee, S.W. and Park, Y.S. (2000) Characterization of recombinant
Dictyostelium discoideum sepiapterin reductase expressed in E.
coli. Mol. Cells 10, 405–410.
[13] Choi, Y.K., Jun, S.-R., Cha, E.-Y., Park, J.S. and Park, Y.S.
(2005) Sepiapterin reductases from Chlorobium tepidum and
Chlorobium limicola catalyze the synthesis of L-threo-tetrahydro-
biopterin from 6-pyruvoyltetrahydropterin. FEMS Microbiol.
Lett. 242, 95–99.
[14] Watts, D.J. and Ashworth, J.M. (1970) Growth of myxameobae
of the cellular slime mould Dictyostelium discoideum in axenic
culture. Biochem. J. 119, 171–174.
[15] Sutoh, K. (1993) A transformation vector for Dictyostelium
discoideum with a new selectable marker bsr. Plasmid 30, 150–154.[16] Kuwayama, H., Obara, S., Morio, T., Katoh, M., Urushihara, H.
and Tanaka, Y. (2002) PCR-mediated generation of a gene
disruption construct without the use of DNA ligase and plasmid
vectors. Nucleic Acids Res. 30, E2.
[17] Adachi, H., Hasebe, T., Yoshinaga, K., Ohta, T. and Sutoh, K.
(1994) Isolation of Dictyostelium discoideum cytokinesis mutants
by restriction enzyme-mediated integration of the blasticidin S
resistance marker. Biochem. Biophys. Res. Commun. 205, 1808–
1814.
[18] Kaneko, Y.S., Mori, K., Nakashima, A., Nagatsu, I. and Ota, A.
(2001) Determination of tetrahydrobiopterin in murine locus
coeruleus by HPLC with ﬂuorescence detection. Brain Res.
Protocols 8, 25–31.
[19] Lee, S.W., Lee, H.W., Chung, H.J., Kim, Y.-A., Kim, Y.J.,
Chung, J.H. and Park, Y.S. (1999) Identiﬁcation of the genes
encoding enzymes involved in the early biosynthetic pathway of
pteridines in Synechocystis sp. PCC 6803. FEMS Microbiol. Lett.
176, 169–176.
[20] Woo, H.J., Kang, J.Y., Choi, Y.K. and Park, Y.S. (2002)
Production of sepiapterin in Escherichia coli by coexpression of
cyanobacterial GTP cyclohydrolase I and human 6-pyruvoyltet-
rahydropterin synthase. Appl. Environ. Microbiol. 68, 3138–3140.
